Recall: Zelnorm

Jul. 2022Pharmacy Updates
Alfasigma USA Inc. will no longer make Zelnorm® available in the U.S. marketplace effective June 30, 2022. This medication is used to treat irritable bowel syndrome with constipation (IBS-C) in adult women younger than 65 years old. Read the full text of the Zelnorm recall.

Recent Announcements

CME Webinar: Getting it Right from the Start: Identifying Patient Advanced Care Directives

Please join us for a live, CME-accredited webinar on Thursday, Oct. 15, 2026 that will educate providers on identifying advanced directives and surrogate decision makers on admission.
Oct. 2026Education/Webinars

CME Webinar: Navigating Grief Conversations

Please join us for a live, CME-accredited webinar on Thursday, Nov. 12, 2026, that will enhance your confidence and effectiveness in supporting patients dealing with loss & grief.
Oct. 2026Education/Webinars

Provider OnLine Login Changes for UPMC Employees and UPMC Children’s Hospital of Pittsburgh Employees

UPMC employees and UPMC Children’s Hospital of Pittsburgh employees will now use their email address to access Provider OnLine.
Oct. 2026Important Notices